IBB - iShares NASDAQ Biotechnology Index Fund Summary, Stock Quote and News | Benzinga

Market Overview

101.94 -1.95 (-1.88%)

After Hours 101.99 (%)

Data as of Dec 14, 2018

Prev. Close 103.89
Price Open 102.76
Volume 1,614,646
Day's Range 101.7 - 103.65
52 Wk Range -
50 Day Moving Avg. 107.57
PE Ratio 0
Shares Outstanding
Market Cap

Trade IBB stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch Shanthi RexalineFri, 14 Dec 2018 07:47:30 -0500
The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen Shanthi RexalineThu, 13 Dec 2018 07:56:25 -0500
The Daily Biotech Pulse: Legal Victory For Boston Scientific, Alder Gets New CFO, FDA Go-Ahead For BioXcel Shanthi RexalineWed, 12 Dec 2018 08:07:11 -0500
The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings Shanthi RexalineTue, 11 Dec 2018 08:22:15 -0500
The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings Shanthi RexalineSat, 08 Dec 2018 10:02:18 -0500
The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut Shanthi RexalineFri, 07 Dec 2018 08:04:52 -0500
The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering Shanthi RexalineThu, 06 Dec 2018 07:56:09 -0500
The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO Shanthi RexalineTue, 04 Dec 2018 07:59:03 -0500
The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs Shanthi RexalineSun, 02 Dec 2018 17:51:20 -0500
Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates Shanthi RexalineFri, 30 Nov 2018 13:09:03 -0500
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Strongbridge Biopharma plc Added to the NASDAQ Biotech Index Globe NewswireDec 13, 2017
Aurinia Pharmaceuticals Added to the NASDAQ Biotech Index Business WireDec 11, 2017
BlackRock Announces Share Split for iShares Nasdaq Biotechnology ETF Business WireNov 07, 2017
MediciNova Added to NASDAQ Biotechnology Index Globe NewswireDec 14, 2016
Blueprint Medicines Added to NASDAQ Biotechnology Index PRNewswireDec 17, 2015
Collegium Added to the NASDAQ Biotechnology Index Globe NewswireDec 14, 2015
Vitae Pharmaceuticals Announces Addition to the NASDAQ Biotechnology Index Globe NewswireDec 14, 2015
GW Pharmaceuticals Added to NASDAQ Biotechnology Index Globe NewswireDec 22, 2014
Revance Therapeutics Added to NASDAQ Biotechnology Index Globe NewswireDec 18, 2014
Hyperion Therapeutics Added to Nasdaq Biotechnology Index (NBI) Globe NewswireDec 18, 2014
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Is Tesla Really Heading for Orbit? TalkMarkets1 day ago
Why Biotech Asset Managers Can (Should?) Make Money In Any Markets Seeking Alpha1 day ago
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks1 day ago
The Zacks Analyst Blog Highlights: Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceutical and Biogen Zacks2 days ago
Healthcare And Biotechnology Dashboard - Update Seeking Alpha3 days ago
Stock Investors Hide Behind the Volatility Mask TalkMarkets4 days ago
Challenges For Gilead's 2 New CEOs Seeking Alpha4 days ago
The Market Withers In The Wind TalkMarkets6 days ago
Is a Rally off the Lows Bullish? TalkMarketsDec 06, 2018
Eye Drug Continues to Drive Regeneron's Growth GuruFocusDec 04, 2018
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Brokerage Center

Compare All Online Brokerages